-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Aptose Biosciences Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2017 to 2023.
- Aptose Biosciences Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $207K, a 73.1% decline year-over-year.
- Aptose Biosciences Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $2.03M, a 55.5% decline year-over-year.
- Aptose Biosciences Inc. annual Share-based Payment Arrangement, Expense for 2023 was $3.65M, a 29.8% decline from 2022.
- Aptose Biosciences Inc. annual Share-based Payment Arrangement, Expense for 2022 was $5.21M, a 59.8% decline from 2021.
- Aptose Biosciences Inc. annual Share-based Payment Arrangement, Expense for 2021 was $12.9M, a 39.6% decline from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)